메뉴 건너뛰기




Volumn 29, Issue 12, 2010, Pages 1465-1467

A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature

Author keywords

Arthritis; IL 6; Still's disease; Tocilizumab

Indexed keywords

ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB;

EID: 78649326282     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1553-9     Document Type: Article
Times cited : (46)

References (9)
  • 1
    • 56349163043 scopus 로고    scopus 로고
    • Adult-onset Still's disease
    • 10.1016/j.berh.2008.08.006 19028363
    • B Fautrel 2008 Adult-onset Still's disease Best Pract Res Clin Rheumatol 22 773 792 10.1016/j.berh.2008.08.006 19028363
    • (2008) Best Pract Res Clin Rheumatol , vol.22 , pp. 773-792
    • Fautrel, B.1
  • 2
    • 38949089775 scopus 로고    scopus 로고
    • Adult-onset still's disease: Pathogenesis, clinical manifestations and therapeutic advances
    • DOI 10.2165/00003495-200868030-00005
    • A Kontzias P Efthimiou 2008 Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances Drugs 68 319 337 1:CAS:528:DC%2BD1cXksFSntL4%3D 10.2165/00003495-200868030-00005 18257609 (Pubitemid 351225811)
    • (2008) Drugs , vol.68 , Issue.3 , pp. 319-337
    • Kontzias, A.1    Efthimiou, P.2
  • 4
    • 0036898472 scopus 로고    scopus 로고
    • Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease
    • DOI 10.1002/art.10620
    • M Iwamoto H Nara D Hirata S Minota N Nishimoto K Yoshizaki 2002 Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease Arthritis Rheum 46 3388 3389 1:CAS:528: DC%2BD3sXjslGgsw%3D%3D 10.1002/art.10620 12483747 (Pubitemid 35453552)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.12 , pp. 3388-3389
    • Iwamoto, M.1    Nara, H.2    Hirata, D.3    Minota, S.4    Nishimoto, N.5    Yoshizaki, K.6
  • 5
    • 58349119558 scopus 로고    scopus 로고
    • Tocilizumab for multi-refractory adult-onset Still's disease
    • 10.1136/ard.2008.088179 19088261
    • M De Bandt B Saint-Marcoux 2009 Tocilizumab for multi-refractory adult-onset Still's disease Ann Rheum Dis 68 153 154 10.1136/ard.2008.088179 19088261
    • (2009) Ann Rheum Dis , vol.68 , pp. 153-154
    • De Bandt, M.1    Saint-Marcoux, B.2
  • 6
    • 60149096148 scopus 로고    scopus 로고
    • A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years
    • 10.1007/s10165-008-0116-2 18762861
    • H Nakahara T Mima N Yoshio-Hoshino M Matsushita J Hashimoto N Nishimoto 2009 A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years Mod Rheumatol 19 69 72 10.1007/s10165-008-0116-2 18762861
    • (2009) Mod Rheumatol , vol.19 , pp. 69-72
    • Nakahara, H.1    Mima, T.2    Yoshio-Hoshino, N.3    Matsushita, M.4    Hashimoto, J.5    Nishimoto, N.6
  • 7
    • 61549119438 scopus 로고    scopus 로고
    • Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab
    • 10.1007/s10067-009-1097-z 19184270
    • K Matsumoto T Nagashima S Takatori Y Kawahara M Yagi M Iwamoto, et al. 2009 Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab Clin Rheumatol 28 485 487 10.1007/s10067-009-1097-z 19184270
    • (2009) Clin Rheumatol , vol.28 , pp. 485-487
    • Matsumoto, K.1    Nagashima, T.2    Takatori, S.3    Kawahara, Y.4    Yagi, M.5    Iwamoto, M.6
  • 8
    • 18644385243 scopus 로고    scopus 로고
    • Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
    • DOI 10.1084/jem.20050473
    • V Pascual F Allantaz E Arce M Punaro J Banchereau 2005 Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade J Exp Med 201 1479 1486 1:CAS:528:DC%2BD2MXktVCmurw%3D 10.1084/jem.20050473 15851489 (Pubitemid 40664091)
    • (2005) Journal of Experimental Medicine , vol.201 , Issue.9 , pp. 1479-1486
    • Pascual, V.1    Allantaz, F.2    Arce, E.3    Punaro, M.4    Banchereau, J.5
  • 9
    • 69549124775 scopus 로고    scopus 로고
    • Targeting interleukin-6 in pediatric rheumatic diseases
    • 10.1097/BOR.0b013e32832f1445 19593141
    • F De Benedetti 2009 Targeting interleukin-6 in pediatric rheumatic diseases Curr Opin Rheumatol 21 533 537 10.1097/BOR.0b013e32832f1445 19593141
    • (2009) Curr Opin Rheumatol , vol.21 , pp. 533-537
    • De Benedetti, F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.